Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Single-cell genomics in AML: extending the frontiers of AML research
Asiri Ediriwickrema, Andrew J. Gentles, Ravindra Majeti
Blood (2022) Vol. 141, Iss. 4, pp. 345-355
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Cooperative CAR targeting to selectively eliminate AML and minimize escape
Sascha Haubner, Jorge Mansilla‐Soto, Sarah Nataraj, et al.
Cancer Cell (2023) Vol. 41, Iss. 11, pp. 1871-1891.e6
Open Access | Times Cited: 41
Consensus on the monitoring, treatment, and prevention of leukaemia relapse after allogeneic haematopoietic stem cell transplantation in China: 2024 update
Yu Wang, Ying‐Jun Chang, Jing Chen, et al.
Cancer Letters (2024) Vol. 605, pp. 217264-217264
Closed Access | Times Cited: 18
Targeted Therapy Development in Acute Myeloid Leukemia
Tulasigeri M. Totiger, Anirban Ghoshal, Jenna Zabroski, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 641-641
Open Access | Times Cited: 24
Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity
Matthew Schwede, Katharina Jahn, Jack Kuipers, et al.
Leukemia (2024) Vol. 38, Iss. 7, pp. 1501-1510
Open Access | Times Cited: 7
Prognostic heterogeneity and clonal dynamics within distinct subgroups of myelodysplastic syndrome and acute myeloid leukemia with TP53 disruptions
Shyam A. Patel, Jan Černý, William K Gerber, et al.
eJHaem (2023) Vol. 4, Iss. 4, pp. 1059-1070
Open Access | Times Cited: 13
Chimeric antigen receptor (CAR) modified T Cells in acute myeloid leukemia: limitations and expectations
Beatriz Guijarro-Albaladejo, Cristina Marrero-Cepeda, Eduardo Rodríguez‐Arbolí, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 5
Single cell RNA sequencing improves the next generation of approaches to AML treatment: challenges and perspectives
Zahra Khosroabadi, Samaneh Azaryar, Hassan Dianat‐Moghadam, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
The Emerging Role of CD8+ T Cells in Shaping Treatment Outcomes of Patients with MDS and AML
Athanasios Tasis, Theodoros Spyropoulos, Ioannis Mitroulis
Cancers (2025) Vol. 17, Iss. 5, pp. 749-749
Open Access
Clonal dynamics and copy number variants by single‐cell analysis in leukemic evolution of myeloproliferative neoplasms
Laura Calabresi, Chiara Carretta, Simone Romagnoli, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 10, pp. 1520-1531
Open Access | Times Cited: 11
Integrated Analysis of Single-Cell RNA-Seq and Bulk RNA-Seq Unravels the Molecular Feature of Tumor-Associated Macrophage of Acute Myeloid Leukemia
Xin Gao
Genetics Research (2024) Vol. 2024, pp. 1-12
Open Access | Times Cited: 4
Unveiling novel insights in acute myeloid leukemia through single-cell RNA sequencing
Jianbiao Zhou, Wee Joo Chng
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Iron overload mediates cytarabine resistance in AML by inhibiting the TP53 signaling pathway
Yan Jia, Ling Li, Ying Li, et al.
Acta Biochimica et Biophysica Sinica (2025)
Open Access
Impact of single nucleotide polymorphisms of immunomodulatory factors on treatment response and prognosis in acute myeloid leukemia
Mingying Li, Tao Sun, Mengyuan Chang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemia
Arnaud Métois, Marie-Ève Bordeleau, Louis Thérêt, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Single‐cell RNA Sequencing Contributes to the Treatment of Acute Myeloid Leukaemia With Hematopoietic Stem Cell Transplantation, Chemotherapy, and Immunotherapy
Raed Obaid Saleh, Ahmed Hjazi, Safia Obaidur Rab, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 4
Closed Access
CXCR4-Mediated Codelivery of FLT3 and BCL-2 Inhibitors for Enhanced Targeted Combination Therapy of FLT3-ITD Acute Myeloid Leukemia
Jiakun Yang, Peng Zhang, Yumin Mao, et al.
Biomacromolecules (2024) Vol. 25, Iss. 7, pp. 4569-4580
Closed Access | Times Cited: 2
Flow cytometry in acute myeloid leukemia and detection of minimal residual disease
Qihui Cai, Haiqiang Lan, Yi Deng, et al.
Clinica Chimica Acta (2024) Vol. 564, pp. 119945-119945
Open Access | Times Cited: 2
Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity
Ravindra Majeti, Matthew Schwede, Katharina Jahn, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 4
From hypoxia single‐cell gene signatures to HIF targeting of AML leukemic stem cells
Thomas Mercher, Juerg Schwaller
HemaSphere (2024) Vol. 8, Iss. 3
Open Access | Times Cited: 1
A single cell framework identifies functionally and molecularly distinct multipotent progenitors in adult human hematopoiesis
Asiri Ediriwickrema, Yusuke Nakauchi, Amy C. Fan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Cytoplasmic TP53INP2 acts as an apoptosis partner in TRAIL treatment: the synergistic effect of TRAIL with venetoclax in TP53INP2-positive acute myeloid leukemia
Jun Ren, Junpeng Huang, Zailin Yang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 1
Enhanced Antitumor Efficacy of Cytarabine and Idarubicin in Acute Myeloid Leukemia Using Liposomal Formulation: In Vitro and In Vivo Studies
Chunxia Zhu, Yang Liu, Xiaojun Ji, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1220-1220
Open Access | Times Cited: 1
Single-Cell Next-Generation Sequencing to Monitor Hematopoietic Stem-Cell Transplantation: Current Applications and Future Perspectives
Olisaemeka Ogbue, Serhan Ünlü, Gogo-ogute E. Ibodeng, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2477-2477
Open Access | Times Cited: 3
LC–MS/MS method for the quantitation of decitabine and venetoclax in rat plasma after SPE: Application to pharmacokinetic study
Abdulaziz I. Alnasser, Mohamed Hefnawy, Abdullah M. Al‐Hossaini, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 9, pp. 101693-101693
Open Access | Times Cited: 3
Challenges facing minimal residual disease testing for acute myeloid leukemia and promising strategies to overcome them
Siqi Li, Man Chen, Xi-Yi Huang, et al.
Expert Review of Hematology (2023) Vol. 16, Iss. 12, pp. 981-990
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top